PCV11 ASSESSMENT AND QUANTIFICATION OF THE BENEFIT RISK RATIO OF ROSUVASTATIN AND ATORVASTATIN FROM A META-ANALYSIS OF HEAD TO HEAD RANDOMISED CONTROLLED TRIALS

May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70599-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)70599-4/fulltext
Section Title :
Section Order : 327
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70599-4&doi=10.1016/S1098-3015(10)70599-4
HEOR Topics :
Tags :
Regions :